{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:00:58Z","timestamp":1790413258477,"version":"4.1.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Cryptococcal meningoencephalitis (CM) continues to cause major morbidity and mortality in a range of patients such as those immunosuppressed from HIV and with biologic immunosuppressants, including treatments of autoimmunity, malignancies, and conditioning regimens for transplantation. It is currently the most common cause of non-viral meningitis in the United States. Infections in previously healthy patients also develop with autoantibodies to granulocyte-macrophage colony stimulating factor or with monogenetic defects. In all populations, mortality and significant long-term morbidity occur in 30\u201350% despite therapy, and immune reconstitution and post-infectious inflammatory response syndromes complicate management. To help with these difficult cases, we present here a practical tutorial of the care of a range of patients with CM in the absence of HIV\/AIDS.<\/jats:p>","DOI":"10.3389\/fneur.2022.994396","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:22:13Z","timestamp":1669900933000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Kenneth","family":"Ssebambulidde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seher H.","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Hargarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Chittiboina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmojtaba","family":"Seyedmousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieren A.","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima A.","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgette Jeanne","family":"Billioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson","year":"2017","journal-title":"Nat Rev Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/ciz193","article-title":"A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus-negative people in the United States","volume":"70","author":"Marr","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis","author":"Rajasingham","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e60431","DOI":"10.1371\/journal.pone.0060431","article-title":"Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status","volume":"8","author":"Brizendine","year":"2013","journal-title":"PLoS ONE."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e56269","DOI":"10.1371\/journal.pone.0056269","article-title":"Epidemiology of cryptococcal meningitis in the US: 1997\u20132009","volume":"8","author":"Pyrgos","year":"2013","journal-title":"PLoS ONE."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"MBio"},{"key":"B8","doi-asserted-by":"publisher","first-page":"ofx082","DOI":"10.1093\/ofid\/ofx082","article-title":"Williamson, susceptibility to cryptococcal meningoencephalitis associated with idiopathic CD4(+) lymphopenia and secondary germline or acquired defects","volume":"4","author":"Panackal","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e00357","DOI":"10.1128\/mSphere.00357-16","article-title":"The case for adopting the \u201cspecies complex\u201d nomenclature for the etiologic agents of cryptococcosis","volume":"2","author":"Kwon-Chung","year":"2017","journal-title":"mSphere"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0270821","DOI":"10.1128\/mBio.02708-21","article-title":"Cryptococcus gattii species complex as an opportunistic pathogen: underlying medical conditions associated with the infection","volume":"12","author":"Yang","year":"2021","journal-title":"mBio."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1128\/AEM.03697-12","article-title":"Susceptibility of intact germinating arabidopsis thaliana to the human fungal pathogen Cryptococcus","volume":"79","author":"Warpeha","year":"2013","journal-title":"Appl Environ Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1369-5274(03)00082-1","article-title":"'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi\u2014the Cryptococcus neoformans paradigm","volume":"6","author":"Casadevall","year":"2003","journal-title":"Current Opinion Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/13693786310001616500","volume":"42","author":"Malliaris","year":"2004","journal-title":"Cryptococcus neoformans var gattii can exploit Acanthamoeba castellanii for growth. Med Mycol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5334\/aogh.3524","article-title":"Delays in cryptococcal meningitis diagnosis and care: a mixed methods study in rural Uganda","volume":"88","author":"Link","year":"2022","journal-title":"Ann Glob Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.cmi.2016.04.022","article-title":"Cryptococcosis-the impact of delay to diagnosis","volume":"22","author":"Aye","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.carrev.2021.08.012","article-title":"Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: a case report and literature review","volume":"38","author":"Sulemankhil","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"B20","first-page":"61","article-title":"Cryptococcal infections in non-HIV-infected patients","volume":"124","author":"Pappas","year":"2013","journal-title":"Trans Am Clin Climatol Assoc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/MOP.0000000000000689","article-title":"Intracranial hypertension: a current review","volume":"30","author":"Jordan","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00005792-199307000-00001","article-title":"Catastrophic visual loss due to Cryptococcus neoformans meningitis","volume":"72","author":"Rex","year":"1993","journal-title":"Medicine."},{"key":"B23","volume-title":"Cryptococcosis, Lea and Febiger.","author":"Kwon-Chung","year":"1992"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1097\/MAO.0000000000002242","article-title":"Williamson audiologic and otologic complications of cryptococcal meningoencephalitis in non-HIV previously healthy patients","volume":"40","author":"King","year":"2019","journal-title":"Otol Neurotol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/cid\/ciw739","article-title":"Spinal arachnoiditis as a complication of cryptococcal meningoencephalitis in non-HIV previously healthy adults","volume":"64","author":"Panackal","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"18442","DOI":"10.1038\/s41598-019-54876-7","article-title":"HIV-negative cryptococcal meningoencephalitis results in a persistent frontal-subcortical syndrome","volume":"9","author":"Traino","year":"2019","journal-title":"Sci Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2214\/ajr.154.3.2106227","article-title":"CT of intracranial cryptococcosis","volume":"154","author":"Popovich","year":"1990","journal-title":"AJR Am J Roentgenol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1038\/s41598-017-09694-0","article-title":"Choroid plexitis and ependymitis by magnetic resonance imaging are biomarkers of neuronal damage and inflammation in HIV-negative cryptococcal meningoencephalitis","volume":"7","author":"Hammoud","year":"2017","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1148\/rg.26si065501","article-title":"State-of-the-art imaging of acute stroke","volume":"26","author":"Srinivasan","year":"2006","journal-title":"Radiographics."},{"key":"B30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1590\/0100-3984.2016.0017","article-title":"Magnetic resonance imaging findings in central nervous system cryptococcosis: comparison between immunocompetent and immunocompromised patients","volume":"50","author":"Duarte","year":"2017","journal-title":"Radiol Bras."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10096-017-2941-8","article-title":"Magnetic resonance imaging study of cryptococcal neuroradiological lesions in HIV-negative cryptococcal meningitis","volume":"36","author":"Zhong","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E64","DOI":"10.1086\/340525","article-title":"Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus","volume":"34","author":"Liliang","year":"2002","journal-title":"Clin Infect Dis."},{"key":"B33","year":""},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0127117","DOI":"10.1371\/journal.pone.0127117","article-title":"Evaluation of a new cryptococcal antigen lateral flow immunoassay in serum, cerebrospinal fluid and urine for the diagnosis of cryptococcosis: a meta-analysis and systematic review","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS ONE."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1128\/jcm.32.7.1680-1684.1994","article-title":"Comparison of commercial kits for detection of cryptococcal antigen","volume":"32","author":"Tanner","year":"1994","journal-title":"J Clin Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e49541","DOI":"10.1371\/journal.pone.0049541","article-title":"Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory","volume":"7","author":"McMullan","year":"2012","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/JCM.02223-15","article-title":"Performance of the cryptococcal antigen lateral flow assay in non-HIV-related cryptococcosis","volume":"54","author":"Jitmuang","year":"2016","journal-title":"J Clin Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1128\/JCM.02017-14","article-title":"Enzyme immunoassay vs. latex agglutination cryptococcal antigen assays in adults with non-HIV-related cryptococcosis","volume":"52","author":"Panackal","year":"2014","journal-title":"J Clin Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.cmi.2020.01.007","article-title":"Evaluation of the biofire filmarray meningitis\/encephalitis assay for the detection of Cryptococcus neoformans \/gattii","volume":"26","author":"Van","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1086\/345956","article-title":"Primary cutaneous cryptococcosis: a distinct clinical entity","volume":"36","author":"Neuville","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/13693780801961345","article-title":"Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis","volume":"46","author":"Saha","year":"2008","journal-title":"Med Mycol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/myc.12882","article-title":"Cryptococcal meningitis is a cause for cross-reactivity in cerebrospinal fluid assays for anti-histoplasma, anti-coccidioides and anti-blastomyces antibodies","volume":"62","author":"Bahr","year":"2019","journal-title":"Mycoses."},{"key":"B43","first-page":"1145","article-title":"Combined fontana-masson-mucin staining of Cryptococcus neoformans","volume":"115","author":"Lazcano","year":"1991","journal-title":"Arch Pathol Lab Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fmicb.2014.00740","article-title":"Skeletal cryptococcosis from 1977 to 2013","volume":"5","author":"Zhou","year":"2014","journal-title":"Front Microbiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.amjms.2020.12.007","article-title":"Disseminated cryptococcosis in an immunocompetent host presenting as osteomyelitis and leading to adrenal insufficiency","volume":"363","author":"Hsu","year":"2022","journal-title":"Am J Med Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jiph.2017.09.015","article-title":"Systemic cryptococcosis in an immune-competent child","volume":"11","author":"Saini","year":"2018","journal-title":"J Infect Public Health."},{"key":"B47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin Infect Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e00166","DOI":"10.1128\/mBio.00166-17","article-title":"Microevolution of Serial Clinical Isolates of Cryptococcus neoformans var. grubii and C. gattii","volume":"8","author":"Chen","year":"2017","journal-title":"mBio."},{"key":"B49","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1172\/JCI124516","article-title":"Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis","volume":"129","author":"Stone","year":"2019","journal-title":"J Clin Invest."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/mmy\/myab046","article-title":"Antifungal susceptibility testing with YeastONE is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia","volume":"59","author":"Yang","year":"2021","journal-title":"Med Mycol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1093\/cid\/ciz076","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B","volume":"68","author":"Groll","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMoa2111904","article-title":"Ambition study, single-dose liposomal amphotericin B treatment for cryptococcal meningitis","volume":"386","author":"Jarvis","year":"2022","journal-title":"N Engl J Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"Loyse","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0159727","DOI":"10.1371\/journal.pone.0159727","article-title":"Early fungicidal activity as a candidate surrogate endpoint for all-cause mortality in cryptococcal meningitis: a systematic review of the evidence","volume":"11","author":"Montezuma-Rusca","year":"2016","journal-title":"PLoS ONE."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1007\/s11999-015-4232-y","article-title":"Liposomal formulation decreases toxicity of amphotericin B in vitro and in vivo","volume":"473","author":"Roberts","year":"2015","journal-title":"Clin Orthop Relat Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","article-title":"Prognostic factors in cryptococcal meningitis. A study in 111 ases","volume":"80","author":"Diamond","year":"1974","journal-title":"Ann Intern Med"},{"key":"B59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome national institute of allergy and infectious diseases mycoses study group and AIDS clinical trials group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California collaborative treatment group","volume":"324","author":"Bozzette","year":"1991","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"ofv157","DOI":"10.1093\/ofid\/ofv157","article-title":"Cerebrospinal fluid culture positivity and clinical outcomes after amphotericin-based induction therapy for cryptococcal meningitis","volume":"2","author":"Rolfes","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"378","DOI":"10.7196\/SAMJ.3515","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis","volume":"100","author":"Jarvis","year":"2010","journal-title":"S Afr Med J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1365-3156.2010.02622.x","article-title":"Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia Trop","volume":"15","author":"Espie","year":"2010","journal-title":"Med Int Health."},{"key":"B64","article-title":"HIV.gov","year":"2021"},{"key":"B65","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2012.02.018","article-title":"Cryptococcus gattii, Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility","volume":"73","author":"Lockhart","year":"2012","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s10096-016-2731-8","article-title":"Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6\/VGII) isolates from Southern Brazil","volume":"35","author":"Herkert","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11046-021-00566-w","article-title":"Successful isavuconazole salvage therapy for a Cryptococcus deuterogattii (AFLP6\/VGII) disseminated infection in a European immunocompetent patient","volume":"186","author":"Cuetara","year":"2021","journal-title":"Mycopathologia"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e01184","DOI":"10.1128\/AAC.01184-19","article-title":"Low central nervous system posaconazole concentrations during cerebral phaeohyphomycosis","volume":"63","author":"Barde","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"B69","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures","volume":"23","author":"Bicanic","year":"2009","journal-title":"AIDS."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"ofac416","DOI":"10.1093\/ofid\/ofac416","article-title":"Therapeutic lumbar punctures in human immunodeficiency virus-associated cryptococcal meningitis: should opening pressure direct management?","volume":"9","author":"Kagimu","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1473-3099(10)70170-5","article-title":"International network for the study of, Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions","volume":"10","author":"Haddow","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/TP.0b013e318236cd1a","article-title":"How I treat cryptococcosis in organ transplant recipients","volume":"93","author":"Singh","year":"2012","journal-title":"Transplantation."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1004884","DOI":"10.1371\/journal.ppat.1004884","article-title":"Paradoxical immune responses in non-HIV cryptococcal meningitis","volume":"11","author":"Panackal","year":"2015","journal-title":"PLoS Pathog."},{"key":"B75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12281-019-00345-7","article-title":"Clinical aspects of immune damage in cryptococcosis","volume":"13","author":"Seher","year":"2019","journal-title":"Current Fungal Infect Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"eaba2502","DOI":"10.1126\/sciadv.aba2502","article-title":"Chemokine receptor CXCR3 is required for lethal brain pathology but not pathogen clearance during cryptococcal meningoencephalitis","volume":"6","author":"Xu","year":"2020","journal-title":"Sci Adv"},{"key":"B77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/cid\/cir276","article-title":"Opportunistic infection-associated immune reconstitution syndrome in transplant recipients","volume":"53","author":"Sun","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1189\/jlb.1002476","article-title":"The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation","volume":"74","author":"Vecchiarelli","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1371\/journal.ppat.0020120","article-title":"Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan","volume":"2","author":"Yauch","year":"2006","journal-title":"PLoS Pathog"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/infdis\/jiy286","article-title":"Novel treatment of cryptococcal meningitis via neurapheresis therapy","volume":"218","author":"Smilnak","year":"2018","journal-title":"J Infect Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/infdis\/jit271","article-title":"Cryptococcosis-IRIS is associated with lower Cryptococcus-specific IFN-gamma responses before antiretroviral therapy but not higher T-cell responses during therapy","volume":"208","author":"Chang","year":"2013","journal-title":"J Infect Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e2789","DOI":"10.1093\/cid\/ciaa1901","article-title":"Outcomes in previously healthy cryptococcal meningoencephalitis patients treated with pulse - taper corticosteroids for post-infectious inflammatory syndrome","volume":"73","author":"Anjum","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ana.24408","article-title":"Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis","volume":"78","author":"Komori","year":"2015","journal-title":"Ann Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/jhin.1998.0610","article-title":"The prognostic factors of cryptococcal meningitis in HIV-negative patients","volume":"42","author":"Lu","year":"1999","journal-title":"J Hosp Infect"},{"key":"B85","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","article-title":"Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B86","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1590\/S0482-50042012000400009","article-title":"Committee for, R Bone Metabolic Disorders of the Brazilian Society of, A Brazilian Medical, M Brazilian Association of Physical, and Rehabilitation, Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"52","author":"Pereira","year":"2012","journal-title":"Rev Bras Reumatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1513\/pats.200402-002MS","article-title":"Regulation of inflammatory cell function by corticosteroids","volume":"1","author":"Belvisi","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"B88","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/ecp.11.1","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls","volume":"4","author":"Dietrich","year":"2011","journal-title":"Exp Rev Clin Pharmacol."},{"key":"B89","article-title":"Adjunctive Corticosteroids in HIV-associated cryptococcal meningitis: a randomised controlled trial in African and Southeast Asian Adults","volume-title":"55th Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Beardsley","year":"2015"},{"key":"B90","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-0-387-09550-9_11","article-title":"The damage-response framework of microbial pathogenesis and infectious diseases","volume":"635","author":"Pirofski","year":"2008","journal-title":"Adv Exp Med Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e01175","DOI":"10.1128\/mBio.01175-20","article-title":"Pathogenesis of COVID-19 from the perspective of the damage-response framework","volume":"11","author":"Pirofski","year":"2020","journal-title":"mBio"},{"key":"B92","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/jnnp-2017-315830","article-title":"Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis","volume":"89","author":"Mehta","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B93","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/09638280500534796","article-title":"Recovery plateau following stroke: fact or fiction?","volume":"28","author":"Demain","year":"2006","journal-title":"Disabil Rehabil."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa1800762","article-title":"Pred, prednisone for the prevention of paradoxical tuberculosis-associated IRIS","volume":"379","author":"Meintjes","year":"2018","journal-title":"N Engl J Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcal Collaborative Transplant Study, Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1086\/592690","article-title":"Cryptococcosis in solid organ transplant recipients: current state of the science","volume":"47","author":"Singh","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e12910","DOI":"10.1111\/tid.12910","article-title":"Perfect, Colombo AL. Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system","volume":"20","author":"Ponzio","year":"2018","journal-title":"Transpl Infect Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5812\/jnp.6","article-title":"Nephro and neurotoxicity of calcineurin inhibitors and mechanisms of rejections: a review on tacrolimus and cyclosporin in organ transplantation","volume":"1","author":"Tolou-Ghamari","year":"2012","journal-title":"J Nephropathol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1155\/2008\/305234","article-title":"Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies","volume":"15","author":"Vahid","year":"2008","journal-title":"Can Respir J"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e12751","DOI":"10.1111\/tid.12751","article-title":"Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4","volume":"19","author":"Groll","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"807197","DOI":"10.1155\/2013\/807197","article-title":"Pulmonary and meningeal cryptococcosis after corticosteroid therapy for autoimmune hepatitis: coexistence of cryptococci within pulmonary cancer nodule","volume":"2013","author":"Yuri","year":"2013","journal-title":"Case Rep Pathol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1172\/JCI136068","article-title":"FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages","volume":"130","author":"Bryan","year":"2020","journal-title":"J Clin Invest."},{"key":"B104","doi-asserted-by":"publisher","first-page":"103675","DOI":"10.1016\/j.msard.2022.103675","article-title":"A comprehensive review of varicella-zoster virus, herpes simplex virus and cryptococcal infections associated with sphingosine-1-phosphate receptor modulators in multiple sclerosis patients","volume":"59","author":"Sharma","year":"2022","journal-title":"Mult Scler Relat Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.994396\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:22:19Z","timestamp":1669900939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.994396\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":104,"alternative-id":["10.3389\/fneur.2022.994396"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.994396","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"994396"}}